StockNews.com Downgrades Cimpress (NASDAQ:CMPR) to Buy
StockNews.com lowered shares of Cimpress (NASDAQ:CMPR – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on...
Nurix Therapeutics (NASDAQ:NRIX) Given Overweight Rating at Stephens
Stephens restated their overweight rating on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a research report sent to investors on Monday, Benzinga reports....
Leerink Partners Initiates Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD)
Leerink Partners began coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a report released on Monday, StockNewsAPI reports. The firm issued...
TransDigm Group (NYSE:TDG) Price Target Increased to $1,555.00 by Analysts at JPMorgan Chase & Co.
TransDigm Group (NYSE:TDG – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $1,435.00 to $1,555.00 in a research note issued...
Royal Bank of Canada Increases Entergy (NYSE:ETR) Price Target to $140.00
Entergy (NYSE:ETR – Free Report) had its price objective hoisted by Royal Bank of Canada from $137.00 to $140.00 in a research report report published...
Affirm Holdings, Inc. (NASDAQ:AFRM) Short Interest Down 8.4% in September
Affirm Holdings, Inc. (NASDAQ:AFRM – Get Free Report) was the target of a large decline in short interest during the month of September. As of...
